期刊文献+

临床路径在结节性甲状腺肿手术中的应用 被引量:3

The Study and Practice of Clinical Pathway in the Treatment of Nodular Goiter
下载PDF
导出
摘要 目的:探讨临床路径在结节性甲状腺肿手术患者中应用的意义。方法:对25例结节性甲状腺肿拟施手术患者按临床路径流程进行治疗和护理(临床路径组),并与同期同类25例按传统常规进行治疗和护理的手术患者(对照组)在住院天数、住院总费用、患者的满意度方面进行分析和比较。结果:临床路径组患者平均住院8 d,对照组平均住院10 d,2组比较有显著性差异(P<0.05);临床路径组患者平均医疗费用3 957元,对照组平均医疗费用5 115元,2组比较有显著性差异(P<0.05);患者的满意率临床路径组为96.00%,对照组为56.00%,2组比较有显著性差异(P<0.05)。结论:临床路径明显降低了住院费用,减少了住院天数,明显提高了患者的满意度,在临床实践中切实可行。 Objective:To study the application of the clinical pathway(CP)in the treatmentof nodular goiter.Methods:The CP group had 25 cases while the control group had 25 cases.Clinical pathway medical and nursing methods were applied in CP group,and traditional medical and nursing methods in control group.The clinical data of the hospital days,hospital charges,complications and satisfaction of the patients in CP group and control group were studied and a statistical analysis was made.Results:Compared with the control group,the patients of CP group had shorter hospital days(10 vs 8 days),lower charges(5 115 vs 3 957 RMB),and higher satisfaction(56.00% vs 96.00%),there was obvious statistical difference(P0.01).Conclusion:The clinical pathway can lighten the financial burden of patients,reduce postoperative complications,accelerate the postoperative recovery and improve patient satisfaction.
机构地区 遂宁市中心医院
出处 《现代临床医学》 2011年第3期222-223,共2页 Journal of Modern Clinical Medicine
关键词 临床路径 结节性甲状腺肿 医疗护理模式 nodular Goiter clinical pathways medical and nursing methods
  • 相关文献

参考文献2

二级参考文献15

共引文献117

同被引文献19

  • 1王存川.腔镜甲状腺切除术并发症防治[J].临床外科杂志,2004,12(10):594-594. 被引量:48
  • 2陈超萍,倪剑武,谷迪丹,麻仲敏,郑春生.临床护理路径在甲状腺肿瘤手术病人中的应用[J].护理研究(上旬版),2005,19(12):2587-2588. 被引量:8
  • 3Jacobs A. Radiofrequency ablation for liver cancer[J]. Radiol Technol, 2015,86(6) 645 - 664.
  • 4Liu B,Liu L, Hu M,et al. Percutaneous radio frequency ablation for medically inoperable patients with clinical stage I non - small cell lung cancer[J]. Thorac Cancer,2015,6(3) 327 -333.
  • 5Donington J$. Radiofrequency ablation in high - risk stage I non small cell lung cancer[J]. Cancer,2015,121(19):3393- 3394.
  • 6Lim HK, Baek J, Lee H, et al. Efficacy and safety of radiofrequen- cy ablation for treating locoregional recurrence from papillary thy- roid cancer[J]. Eur Radiol,2015,25(1) : 163 - 170.
  • 7Jiang K, Zhang Z, Liu Y, et al. "One - off'complete radiofrequency ablation for hepatocellular carcinoma in "high- risk location"adja- cent to the major bile duct and hepatic blood vessel[J]. Cell Bio- chem Biophys,2014,69(3) :605 - 617.
  • 8Km HY,Ryu W,Woo S,et al: Primary papillary thyroid carcino- ma previously treated incompletely with radiofrequeney ablation [J]. J Cancer Res Ther,2010,6(3) :310- 312.
  • 9Ugurlu MU, Uprak K, Akpinar I, et al. Radiofrequency ablation of benign symptomatic thyroid nodules: prospective safety and efficacy study[J]. World J Surg,2015,39(4) :961 - 968.
  • 10Wang L,Ge M,Xu D,et al. Ultrasonography- guided percutane- ous radiofrequency ablation for cervical lymph node metastasis from thyroid eareinomaFJ]. J Cancer Res Ther, 2014,10 (Suppl) : 144 - 149.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部